compounders sue fda over ending semaglutide shortage Drug US removal of Wegovy, Ozempic from list The GLP-1 drug shortage is

Additionally, some may opt for complementary procedures like body contouring treatments or non-invasive fat reduction techniques

It reduces appetite, slows gastric emptying, and enhances glucose-dependent insulin secretion while reducing glucagon secretion

It works well for slow mornings or shared meals where a few slices are enough

The recent research also found that although persistence among the 45 percent of the population using weekly-dosed semaglutide (Ozempic and Wegovy ) was somewhat better, still only 1 in 4 of those initiating semaglutide treatment for obesity remained on GLP-1 therapy at two years

With the wide array of telehealth solutions available, there are also emerging solutions that connect patients with the right provider and program, like GLP Winner

Track Lilly's Phase 3 readouts through the rest of 2026, follow MHRA news in 2027, and revisit the question when private prescription access opens